Raymond James Raises Veeva Systems Inc. (NYSE:VEEV) Target Price by $ 50 To $ 335.00

Veeva Systems Inc. (NYSE:VEEV) shares have more than 12.85 percent upside potential from the existing levels. This is based on the revised price target of Raymond James at $ 335.00 on the stock. Incidentally, the brokerage raised its price objective by $ 50 from its earlier level of $ 285.00. However, Raymond James has maintained its Outperform rating on the stock, Benzinga reported.

Shares of Veeva Systems Inc. traded up $ 6.10 or 2.10 percent on Friday, reaching $ 296.85 with volume of 709.20 thousand shares. Veeva Systems Inc. has traded high as $ 302.11 and has cracked $ 291.81 on the downward trend According to the previous trading day, closing price of $ 296.85, representing a 146.17 % increase from the 52 week low of $ 118.11 and a 7.4 % decrease over the 52 week high of $ 313.99.

With respect to the key metrics, Veeva Systems Inc. stock has advanced $ 54.55 or 23.00 percent, reaching $ 242.30 during the simple moving average (SMA) period of 200 days. Similarly, the stock has increased $ 14.02 or 5.00 percent, before arriving at $ 282.83 during the SMA50-day period.

Veeva Systems Inc. recently reported second quarter financial results on August 27, 2020, after market close, the Pleasanton based company reported income for the second quarter of $ 0.72 per share, from the revenue of $ 353.68 million. The quarterly earnings boosted 30.91 percent compared with the same quarter last year. The consensus estimates are income of $ 0.64 per share from $ 340.12 million in revenue. The bottom line results beat street analysts by $ 0.08 or 12.50 percent, at the same time, top line results outshined analysts by $ 13.56 million or 3.99 percent.

Moving ahead, the consensus estimates from Thomson Reuters for the third quarter are income of $ 0.68 per share from $ 361.40 million in revenue. For the full year, analysts predict revenues of $ 1419.50 million, while looking forward to income of $ 2.67 per share.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.

error: Content is protected !!
Exit mobile version